Post-chemotherapy neutropenia with high risk of developing infection in patients with acute leukemia undergoing induction research hub

A multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients: efficacy and microbiologic safety.

This study compares two antibiotics, fosfomycin and ciprofloxacin, for treating fever in patients with blood cancers when their immune system is weak after chemotherapy. It aims to see which one works better and is safer for preventing serious infections.